2016 Q2 Form 10-Q Financial Statement

#000089817316000359 Filed on August 08, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q2
Revenue $2.177B $2.036B
YoY Change 6.94% 10.2%
Cost Of Revenue $1.050B $976.7M
YoY Change 7.45% 8.98%
Gross Profit $1.127B $1.059B
YoY Change 6.46% 11.35%
Gross Profit Margin 51.78% 52.02%
Selling, General & Admin $702.1M $673.0M
YoY Change 4.32% 9.54%
% of Gross Profit 62.29% 63.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $53.60M $51.00M
YoY Change 5.1% 7.37%
% of Gross Profit 4.76% 4.82%
Operating Expenses $702.1M $673.0M
YoY Change 4.32% 9.54%
Operating Profit $425.1M $385.8M
YoY Change 10.19% 14.65%
Interest Expense -$17.50M -$13.70M
YoY Change 27.74% 11.38%
% of Operating Profit -4.12% -3.55%
Other Income/Expense, Net -$16.27M -$13.56M
YoY Change 19.96% 16.14%
Pretax Income $408.8M $372.2M
YoY Change 9.83% 14.6%
Income Tax $151.0M $138.7M
% Of Pretax Income 36.94% 37.26%
Net Earnings $257.8M $233.5M
YoY Change 10.4% 13.55%
Net Earnings / Revenue 11.84% 11.47%
Basic Earnings Per Share $2.69 $2.32
Diluted Earnings Per Share $2.65 $2.29
COMMON SHARES
Basic Shares Outstanding 95.97M shares 100.5M shares
Diluted Shares Outstanding 97.28M shares 102.1M shares

Balance Sheet

Concept 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $398.0M $260.0M
YoY Change 53.08% -42.6%
Cash & Equivalents $398.3M $260.0M
Short-Term Investments
Other Short-Term Assets $33.83M $37.71M
YoY Change -10.29% -2.14%
Inventory $2.741B $2.561B
Prepaid Expenses
Receivables $186.2M $175.3M
Other Receivables $79.00M $75.00M
Total Short-Term Assets $3.438B $3.109B
YoY Change 10.59% -1.98%
LONG-TERM ASSETS
Property, Plant & Equipment $2.979B $2.744B
YoY Change 8.58% 8.5%
Goodwill $757.1M $756.9M
YoY Change 0.04% 0.07%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $36.14M $43.14M
YoY Change -16.22% 21.83%
Total Long-Term Assets $3.773B $3.559B
YoY Change 6.0% 6.69%
TOTAL ASSETS
Total Short-Term Assets $3.438B $3.109B
Total Long-Term Assets $3.773B $3.559B
Total Assets $7.211B $6.668B
YoY Change 8.14% 2.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.915B $2.536B
YoY Change 14.93% 10.15%
Accrued Expenses $123.0M $137.0M
YoY Change -10.22% 15.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $3.367B $3.007B
YoY Change 11.97% 10.26%
LONG-TERM LIABILITIES
Long-Term Debt $1.886B $1.397B
YoY Change 35.03% 0.07%
Other Long-Term Liabilities $194.7M $217.1M
YoY Change -10.35% 8.17%
Total Long-Term Liabilities $2.081B $217.1M
YoY Change 858.34% 8.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.367B $3.007B
Total Long-Term Liabilities $2.081B $217.1M
Total Liabilities $5.448B $3.224B
YoY Change 68.97% 10.11%
SHAREHOLDERS EQUITY
Retained Earnings $379.6M $726.2M
YoY Change -47.72% -23.44%
Common Stock $1.310B $1.244B
YoY Change 5.35% 6.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.690B $1.970B
YoY Change
Total Liabilities & Shareholders Equity $7.211B $6.668B
YoY Change 8.14% 2.46%

Cashflow Statement

Concept 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income $257.8M $233.5M
YoY Change 10.4% 13.55%
Depreciation, Depletion And Amortization $53.60M $51.00M
YoY Change 5.1% 7.37%
Cash From Operating Activities $325.6M $292.5M
YoY Change 11.32% -5.65%
INVESTING ACTIVITIES
Capital Expenditures -$116.4M -$95.40M
YoY Change 22.01% -14.67%
Acquisitions
YoY Change
Other Investing Activities $1.100M $2.000M
YoY Change -45.0% 42.86%
Cash From Investing Activities -$115.3M -$93.40M
YoY Change 23.45% -15.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -528.0M -412.6M
YoY Change 27.97% 59.92%
NET CHANGE
Cash From Operating Activities 325.6M 292.5M
Cash From Investing Activities -115.3M -93.40M
Cash From Financing Activities -528.0M -412.6M
Net Change In Cash -317.7M -213.5M
YoY Change 48.81% 265.58%
FREE CASH FLOW
Cash From Operating Activities $325.6M $292.5M
Capital Expenditures -$116.4M -$95.40M
Free Cash Flow $442.0M $387.9M
YoY Change 13.95% -8.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000898173
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
94927731 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
O REILLY AUTOMOTIVE INC
CY2015Q4 orly Accrued Benefits And Withholdings
AccruedBenefitsAndWithholdings
72203000 USD
CY2016Q2 orly Accrued Benefits And Withholdings
AccruedBenefitsAndWithholdings
59966000 USD
CY2015Q4 orly Non Financial Assets And Liabilities Fair Value Nonrecurring
NonFinancialAssetsAndLiabilitiesFairValueNonrecurring
0 USD
CY2016Q2 orly Non Financial Assets And Liabilities Fair Value Nonrecurring
NonFinancialAssetsAndLiabilitiesFairValueNonrecurring
0 USD
orly Number Of Days Per Year In Interest Calculation
NumberOfDaysPerYearInInterestCalculation
360 D
CY2015Q2 orly Share Based Compensation Arrangement By Share Based Payment Award Options Antidilutive In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAntidilutiveInPeriodWeightedAverageExercisePrice
206.72
orly Share Based Compensation Arrangement By Share Based Payment Award Options Antidilutive In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAntidilutiveInPeriodWeightedAverageExercisePrice
200.65
CY2016Q2 orly Share Based Compensation Arrangement By Share Based Payment Award Options Antidilutive In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAntidilutiveInPeriodWeightedAverageExercisePrice
262.49
orly Share Based Compensation Arrangement By Share Based Payment Award Options Antidilutive In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAntidilutiveInPeriodWeightedAverageExercisePrice
259.46
CY2016Q1 orly Stock Repurchase Program Increase In Authorized Amount
StockRepurchaseProgramIncreaseInAuthorizedAmount
750000000 USD
CY2016Q2 orly Stock Repurchase Program Increase In Authorized Amount
StockRepurchaseProgramIncreaseInAuthorizedAmount
750000000 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2608231000 USD
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2914641000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
161078000 USD
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
186192000 USD
CY2015Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1444000 USD
CY2016Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2015Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
59101000 USD
CY2016Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
62596000 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1510694000 USD
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1608704000 USD
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1281497000 USD
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1309441000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1051000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1173000 USD
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
226000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
312000 shares
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
285000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
312000 shares
CY2015Q4 us-gaap Assets
Assets
6676684000 USD
CY2016Q2 us-gaap Assets
Assets
7210640000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
3010026000 USD
CY2016Q2 us-gaap Assets Current
AssetsCurrent
3438133000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
250560000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
260042000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
116301000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
398259000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
9482000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
281958000 USD
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
245000000 shares
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
245000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
97737171 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
94881546 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
97737171 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
94881546 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
977000 USD
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
949000 USD
CY2015Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
976727000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1891671000 USD
CY2016Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1049510000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
2048081000 USD
us-gaap Debt Instrument Covenant Compliance
DebtInstrumentCovenantCompliance
Each of the senior notes is subject to certain customary covenants, with which the Company complied as of June 30, 2016.
us-gaap Debt Instrument Description
DebtInstrumentDescription
The Company has issued a cumulative $1.9 billion aggregate principal amount of unsecured senior notes, which are due between January 2021 and March 2026, with UMB as trustee. Interest on the senior notes, ranging from 3.550% to 4.875%, is payable semi-annually and is computed on the basis of a 360-day year.
us-gaap Debt Instrument Maturity Date Range End1
DebtInstrumentMaturityDateRangeEnd1
2026-03-08
us-gaap Debt Instrument Maturity Date Range Start1
DebtInstrumentMaturityDateRangeStart1
2021-01-14
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-15326000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6811000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
79772000 USD
CY2016Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
72961000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
106007000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
106430000 USD
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.42
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.31
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.35
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.24
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
32947000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
30136000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
32947000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
30136000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
757142000 USD
CY2016Q2 us-gaap Goodwill
Goodwill
757130000 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
1058791000 USD
us-gaap Gross Profit
GrossProfit
2045750000 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
1127179000 USD
us-gaap Gross Profit
GrossProfit
2224758000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
372208000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
709872000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
408794000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
814368000 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
138700000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
263500000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
151000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
301200000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
194715000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
279099000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
118804000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
306410000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
34199000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
28837000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
79172000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
25170000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6186000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
110015000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-21807000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-9333000 USD
CY2015Q2 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
100000 USD
us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
400000 USD
CY2016Q2 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
400000 USD
us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
500000 USD
CY2015Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1562000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1606000 shares
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1315000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1357000 shares
CY2015Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
14319000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
28721000 USD
CY2016Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
18701000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
33522000 USD
us-gaap Interest Paid Net
InterestPaidNet
27711000 USD
us-gaap Interest Paid Net
InterestPaidNet
27174000 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
2631015000 USD
CY2016Q2 us-gaap Inventory Net
InventoryNet
2741030000 USD
CY2015Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
16895000 USD
CY2016Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
18535000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6676684000 USD
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7210640000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3046398000 USD
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3366675000 USD
CY2016Q2 us-gaap Long Term Debt
LongTermDebt
1900000000 USD
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1390018000 USD
CY2016Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1886324000 USD
us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
18700000 USD
us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
12500000 USD
us-gaap Loss Contingency Name Of Plaintiff
LossContingencyNameOfPlaintiff
Meridian Creative Alliance
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-506029000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-299037000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-182942000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-217398000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
698453000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
798393000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
233508000 USD
us-gaap Net Income Loss
NetIncomeLoss
446372000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
257794000 USD
us-gaap Net Income Loss
NetIncomeLoss
513168000 USD
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13560000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-26269000 USD
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16267000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-29319000 USD
CY2015Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
72609000 USD
CY2016Q2 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
78824000 USD
CY2015Q4 us-gaap Notes And Loans Receivable Gross Noncurrent
NotesAndLoansReceivableGrossNoncurrent
13219000 USD
CY2016Q2 us-gaap Notes And Loans Receivable Gross Noncurrent
NotesAndLoansReceivableGrossNoncurrent
0 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
385768000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
736141000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
425061000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
843687000 USD
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
29023000 USD
CY2016Q2 us-gaap Other Assets Current
OtherAssetsCurrent
33828000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
34741000 USD
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
36137000 USD
CY2015Q2 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
577000 USD
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
1157000 USD
CY2016Q2 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
1193000 USD
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
1945000 USD
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
232678000 USD
CY2016Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
258295000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
199182000 USD
CY2016Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
194670000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2594000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2655000 USD
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
182000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1295000 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1241000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2258000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
574972000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
856845000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
3784000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
186531000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
220416000 USD
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1981000 USD
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1047000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1608000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
36021000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
32296000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
499160000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1971000 USD
CY2015Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
35223000 USD
CY2016Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
38037000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
34736000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
37550000 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4372250000 USD
CY2016Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4587944000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2861556000 USD
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2979240000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
25000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
678840000 USD
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
379620000 USD
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
2035518000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
3937421000 USD
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
2176689000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
4272839000 USD
CY2015Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
72741000 USD
CY2016Q2 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
71177000 USD
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
673023000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1309609000 USD
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
702118000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1381071000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
11304000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9853000 USD
CY2016Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
7000000000 USD
CY2016Q1 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
CY2016Q2 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
CY2016Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
786400000 USD
CY2015Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1987000 shares
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
2637000 shares
CY2016Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
2075000 shares
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
3306000 shares
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
1961314000 USD
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
1690010000 USD
CY2015Q2 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
221.50
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
218.05
CY2016Q2 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
262.17
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
259.14
CY2015Q2 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
440129000 USD
us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
574932000 USD
CY2016Q2 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
544165000 USD
us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
856802000 USD
CY2015Q4 us-gaap Unsecured Debt
UnsecuredDebt
0 USD
CY2016Q2 us-gaap Unsecured Debt
UnsecuredDebt
0 USD
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
102109000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
102684000 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97282000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97911000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100547000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101078000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95967000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96554000 shares
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 1 - BASIS OF PRESENTATION</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying unaudited condensed consolidated financial statements of O&#8217;Reilly Automotive, Inc. and its subsidiaries (the &#8220;Company&#8221; or &#8220;O&#8217;Reilly&#8221;) have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the </font><font style="font-family:inherit;font-size:10pt;">three and six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, are not necessarily indicative of the results that may be expected for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 9 - RECENT ACCOUNTING PRONOUNCEMENTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May of 2014, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) No. 2014-09, &#8220;Revenue from Contracts with Customers (Topic 606)&#8221; (&#8220;ASU 2014-09&#8221;). Under ASU 2014-09, an entity is required to follow a five-step process to determine the amount of revenue to recognize when promised goods or services are transferred to customers. ASU 2014-09 offers specific accounting guidance for costs to obtain or fulfill a contract with a customer. In addition, an entity is required to disclose sufficient information to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. In August of 2015, the FASB issued ASU No. 2015-14, &#8220;Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date&#8221; (&#8220;ASU 2015-14&#8221;), to defer the effective date of ASU 2014-09 by one year. For public companies, ASU 2015-14 changes ASU 2014-09 to be effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. These ASUs can be adopted retrospectively or as a cumulative-effective adjustment at the date of adoption, with early adoption permitted, but not before December 15, 2016. The Company will adopt this guidance beginning with its first quarter ending March 31, 2018. The Company is in the process of evaluating the potential future impact, if any, of ASU 2014-09 on its consolidated financial position, results of operations and cash flows, and which method of adoption is most appropriate for the Company.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February of 2016, the FASB issued ASU No. 2016-02, &#8220;Leases (Topic 842)&#8221; (&#8220;ASU 2016-02&#8221;). Under ASU 2016-02, an entity will be required to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. ASU 2016-02 offers specific accounting guidance for a lessee, a lessor and sale and leaseback transactions. Lessees and lessors are required to disclose qualitative and quantitative information about leasing arrangements to enable a user of the financial statements to assess the amount, timing and uncertainty of cash flows arising from leases. For public companies, ASU 2016-02 is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, and requires a modified retrospective adoption, with early adoption permitted. The Company will adopt this guidance beginning with its first quarter ending March 31, 2019. The Company is in the process of evaluating the future impact of ASU 2016-02 on its consolidated financial position, results of operations and cash flows.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March of 2016, the FASB issued ASU No. 2016-06, &#8220;Derivatives and Hedging (Topic 815): Contingent Put and Call Options in Debt Instruments&#8221; (&#8220;ASU 2016-06&#8221;). ASU 2016-06 clarifies the requirements for assessing whether contingent call or put options that can accelerate the payment of principal on debt instruments are clearly and closely related to the economic characteristics and risks of the debt hosts and requires entities to solely use the four-step decision sequence, which is already in existence, when assessing the embedded call or put options. For public companies, ASU 2016-06 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period, and can be adopted on a modified retrospective basis, with early adoption permitted. The Company will adopt this guidance beginning with its first quarter ending March 31, 2017. The application of this guidance is not expected to have a material impact on the Company&#8217;s consolidated financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March of 2016, the FASB issued ASU No. 2016-09, &#8220;Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting&#8221; (&#8220;ASU 2016-09&#8221;). Under ASU 2016-09, several aspects of the accounting for share-based payment transactions, including tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows, were simplified. For public companies, ASU 2016-09 is effective for annual reporting beginning after December 15, 2016, including interim periods within that reporting period, with early adoption permitted. ASU 2016-09 includes various adoption methods, depending on the guidance being adopted; amendments related to the timing of when excess tax benefits are recognized, minimum statutory withholding requirements and forfeitures should be applied using a modified retrospective transition method, while the amendments related to the presentation of employee taxes paid on the statement of cash flows should be applied retrospectively, the amendments requiring recognition of excess tax benefits and deficiencies in the income statement should be applied prospectively, and amendments related to the presentation of excess tax benefits on the statement of cash flows should be applied either prospectively or retrospectively. The Company will adopt this guidance beginning with its first quarter ending March 31, 2017. The Company is in the process of evaluating the future impact of ASU 2016-09 on its consolidated financial position, results of operations and cash flows.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June of 2016, the FASB issued ASU No. 2016-13, &#8220;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&#8221; (&#8220;ASU 2016-13&#8221;). Under ASU 2016-13, businesses and other organizations are required to present financial assets, measured at amortized costs basis, at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis, such as trade receivables. The measurement of expected credit loss will be based on historical experience, current conditions, and reasonable and supportable forecasts that affect the collectibility of the reported amount. For public companies, ASU 2016-13 is effective for annual reporting periods beginning after December 15, 2019, including interim periods within that reporting period, and requires a modified retrospective adoption, with early adoption permitted. The Company will adopt this guidance beginning with its first quarter ending March 31, 2020. The application of this guidance is not expected to have a material impact on the Company&#8217;s consolidated financial condition, results of operations or cash flows.</font></div></div>

Files In Submission

Name View Source Status
0000898173-16-000359-index-headers.html Edgar Link pending
0000898173-16-000359-index.html Edgar Link pending
0000898173-16-000359.txt Edgar Link pending
0000898173-16-000359-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
orly-20160630.xml Edgar Link completed
orly-20160630.xsd Edgar Link pending
orly-20160630x10q.htm Edgar Link pending
orly-20160630x10qexhibit311.htm Edgar Link pending
orly-20160630x10qexhibit312.htm Edgar Link pending
orly-20160630x10qexhibit321.htm Edgar Link pending
orly-20160630x10qexhibit322.htm Edgar Link pending
orly-20160630_cal.xml Edgar Link unprocessable
orly-20160630_def.xml Edgar Link unprocessable
orly-20160630_lab.xml Edgar Link unprocessable
orly-20160630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending